Top Markets
#1 Derive Derive +32.49%
#2 Cross Cross +16.87%
#3 Geodnet Geodnet +11.67%
#4 Gama Token Gama Token +9.17%
#5 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.97%
#6 Cap Cap +7.15%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +7.04%
#8 Talus Network Talus Network +6.65%
#9 The Innovation Game The Innovation Game +5.30%
#10 Humanity Humanity +5.15%
Coin of the day
Derive Derive
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Coala-Life Group AB (publ) Coala-Life Group AB (publ)

Coala-Life Group AB (publ)

COALA
Kedudukan dalam Saham #36346
Coala-Life Group AB (publ) is a medical technology firm that specializes in the... Coala-Life Group AB (publ) is a medical technology firm that specializes in the development, manufacturing, and sale of advanced cardiac diagnostics and mobile health products. The company's flagship offering is the Coala Heart Monitor, a comprehensive medical device and associated service designed for digital remote surveillance, analytical assessment, and personal self-screening of heart conditions. Coala-Life Group AB (publ) was founded in 2004 and maintains its headquarters in Uppsala, Sweden.
Harga Saham
$0.0019323
Disegerakkan terakhir: 2024-07-12
Modal Pasaran
$2.78M
Perubahan (1 hari)
16.91%
Perubahan (1 tahun)
0.00%
Negara
SE
Perdagangan Coala-Life Group AB (publ) (COALA)

Kategori

Healthcare
Hasil untuk Coala-Life Group AB (publ) (COALA)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada Coala-Life Group AB (publ), hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi Coala-Life Group AB (publ) dari 2026 hingga 2026
Hasil pada akhir setiap tahun
Tahun Hasil Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil untuk syarikat atau pesaing serupa
Syarikat Hasil Perbezaan Hasil Negara
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US